These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

84 related items for PubMed ID: 7058098

  • 1. Persistence of antibody after the administration of influenza vaccine to children with cancer.
    Sumaya CV, Williams TE.
    Pediatrics; 1982 Feb; 69(2):226-9. PubMed ID: 7058098
    [Abstract] [Full Text] [Related]

  • 2. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
    Walter EB, Neuzil KM, Zhu Y, Fairchok MP, Gagliano ME, Monto AS, Englund JA.
    Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
    [Abstract] [Full Text] [Related]

  • 3. Persistence of influenza serum antibodies in humans following immunization with a bivalent A/Victoria and A/New Jersey vaccine.
    Boucher DW, Contreras G, Furesz J.
    Can Med Assoc J; 1979 Apr 07; 120(7):799-802, 831. PubMed ID: 427686
    [Abstract] [Full Text] [Related]

  • 4. Persistence of influenza A/New Jersey/76 (Hsw1N1) antibody one year after vaccination.
    Noble GR, Kaye HS, O'Brien RJ, Kendal AP, Bregman DJ, Wright PF, Amler RW, Dowdle WR.
    Dev Biol Stand; 1979 Apr 07; 39():253-60. PubMed ID: 604107
    [Abstract] [Full Text] [Related]

  • 5. Assessment of the immune response to trivalent split influenza vaccine in children with solid tumors.
    Bektas O, Karadeniz C, Oguz A, Berberoglu S, Yilmaz N, Citak C.
    Pediatr Blood Cancer; 2007 Dec 07; 49(7):914-7. PubMed ID: 17262793
    [Abstract] [Full Text] [Related]

  • 6. Immune response after influenza vaccination in children with cancer.
    Matsuzaki A, Suminoe A, Koga Y, Kinukawa N, Kusuhara K, Hara T.
    Pediatr Blood Cancer; 2005 Nov 07; 45(6):831-7. PubMed ID: 16007602
    [Abstract] [Full Text] [Related]

  • 7. Clinical reactions and serologic responses after vaccination with whole-virus or split-virus influenza vaccines in children aged 6 to 36 months.
    Bernstein DI, Zahradnik JM, DeAngelis CJ, Cherry JD.
    Pediatrics; 1982 Apr 07; 69(4):404-8. PubMed ID: 7070886
    [Abstract] [Full Text] [Related]

  • 8. Influenza surveillance of Wisconsin (USA) population-detection of A/New Jersey by isolation and serologic monitoring and vaccine evaluation.
    Nelson DB, Inhorn SL.
    Dev Biol Stand; 1982 Apr 07; 39():429-36. PubMed ID: 342315
    [Abstract] [Full Text] [Related]

  • 9. Humoral and cellular immune responses in children given annual immunization with trivalent inactivated influenza vaccine.
    Zeman AM, Holmes TH, Stamatis S, Tu W, He XS, Bouvier N, Kemble G, Greenberg HB, Lewis DB, Arvin AM, Dekker CL.
    Pediatr Infect Dis J; 2007 Feb 07; 26(2):107-15. PubMed ID: 17259871
    [Abstract] [Full Text] [Related]

  • 10. Long-term immunogenicity of a virosomal subunit inactivated influenza vaccine in children with asthma.
    Zuccotti G, Amendola A, Viganò A, Pariani E, Zappa A, Pogliani L, Giacomet V, Savarino A, Podestà A, Rottoli A, Tanzi E, Zanetti A, Radaelli G.
    Vaccine; 2007 Sep 17; 25(37-38):6692-8. PubMed ID: 17697730
    [Abstract] [Full Text] [Related]

  • 11. [Prevalence of antibodies to A/New Jersey/76, A/Victoria/3/75 and B/Hong Kong/5/72 influenza viruses in the population of Milan examined in the late spring of 1976 and evaluation of the past experience of the same population with probable agent of the 1918-20 pandemics].
    Profeta ML, Ferrante P.
    Boll Ist Sieroter Milan; 1976 Sep 30; 55(4):272-8. PubMed ID: 1016579
    [Abstract] [Full Text] [Related]

  • 12. Immune responses of healthy subjects to a single dose of intramuscular inactivated influenza A/Vietnam/1203/2004 (H5N1) vaccine after priming with an antigenic variant.
    Goji NA, Nolan C, Hill H, Wolff M, Noah DL, Williams TB, Rowe T, Treanor JJ.
    J Infect Dis; 2008 Sep 01; 198(5):635-41. PubMed ID: 18694338
    [Abstract] [Full Text] [Related]

  • 13. Differences in antibody responses of mice to intranasal or intraperitoneal immunization with influenza A virus and vaccination with subunit influenza vaccine.
    Fislová T, Sládková T, Gocník M, Mucha V, Varecková E, Kostolanský F.
    Acta Virol; 2005 Sep 01; 49(4):243-50. PubMed ID: 16402681
    [Abstract] [Full Text] [Related]

  • 14. Rapid decline of influenza vaccine-induced antibody in the elderly: is it real, or is it relevant?
    Skowronski DM, Tweed SA, De Serres G.
    J Infect Dis; 2008 Feb 15; 197(4):490-502. PubMed ID: 18275271
    [Abstract] [Full Text] [Related]

  • 15. Serum and mucosal immunologic responses in children following the administration of a new inactivated intranasal anti-influenza vaccine.
    Greenbaum E, Furst A, Kiderman A, Stewart B, Levy R, Schlesinger M, Morag A, Zakay-Rones Z.
    J Med Virol; 2001 Sep 15; 65(1):178-84. PubMed ID: 11505461
    [Abstract] [Full Text] [Related]

  • 16. Safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in infants and children.
    Nolan T, Richmond PC, Formica NT, Höschler K, Skeljo MV, Stoney T, McVernon J, Hartel G, Sawlwin DC, Bennet J, Ryan D, Basser RL, Zambon MC.
    Vaccine; 2008 Nov 25; 26(50):6383-91. PubMed ID: 18801398
    [Abstract] [Full Text] [Related]

  • 17. Immunogenicity and tolerability of inactivated flu vaccine in high risk and healthy children.
    Avila Aguero ML, Soriano-Fallas A, Umaña-Sauma MA, Ulloa-Gutierrez R, Arnoux S.
    Medicina (B Aires); 2007 Nov 25; 67(4):351-9. PubMed ID: 17891930
    [Abstract] [Full Text] [Related]

  • 18. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
    Prabakaran M, Velumani S, He F, Karuppannan AK, Geng GY, Yin LK, Kwang J.
    Virology; 2008 Oct 25; 380(2):412-20. PubMed ID: 18786689
    [Abstract] [Full Text] [Related]

  • 19. Improved antibody responses in infants less than 1 year old using intradermal influenza vaccination.
    Sugimura T, Ito Y, Tananari Y, Ozaki Y, Maeno Y, Yamaoka T, Kudo Y.
    Vaccine; 2008 May 23; 26(22):2700-5. PubMed ID: 18436353
    [Abstract] [Full Text] [Related]

  • 20. Increasing doses of an inactivated influenza A/H1N1 vaccine induce increasing levels of cross-reacting antibody to subsequent, antigenically different, variants.
    Keitel WA, Atmar RL, Nino D, Cate TR, Couch RB.
    J Infect Dis; 2008 Oct 01; 198(7):1016-8. PubMed ID: 18729777
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.